Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

A new study published today in Addiction suggests that Ozempic and similar medications may be able to help with treatment for ...

Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...

Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting ...

This is just a sneak peek at the thousands of consumer insights available to CivicScience clients. Discover more data. The ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.

Lixisenatide requires daily injections, while newer GLP-1-targeting drugs like Ozempic and Wegovy, as well as Eli Lilly’s tirzepatide-based Mounjaro and Zepbound, only need to be given once a ...

Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's ...

What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can ...